Changing epidemiology and etiology of upper and lower gastrointestinal bleeding

K Oakland - Best practice & research Clinical gastroenterology, 2019 - Elsevier
Upper gastrointestinal bleeding (UGIB) develops in the oesophagus, stomach or duodenum
and has an incidence of 47/100,000. Lower GIB (LGIB) develops in the small bowel, colon or …

Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis

V Hernández-Gea, A De Gottardi, FWG Leebeek… - Journal of …, 2019 - Elsevier
Budd-Chiari syndrome and non-cirrhotic non-tumoral portal vein thrombosis are 2 rare
disorders, with several similarities that are categorized under the term splanchnic vein …

[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020

МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter

MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …

Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

K Triantafyllou, P Gkolfakis, IM Gralnek, K Oakland… - …, 2021 - thieme-connect.com
1 ESGE recommends that the initial assessment of patients presenting with acute lower
gastrointestinal bleeding should include: a history of co-morbidities and medications that …

Management of patients with acute lower gastrointestinal bleeding: an updated ACG guideline

N Sengupta, JD Feuerstein, V Jairath… - Official journal of the …, 2023 - journals.lww.com
Acute lower gastrointestinal bleeding (LGIB) is a common reason for hospitalization in the
United States and is associated with significant utilization of hospital resources, as well as …

Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: A nationwide propensity score–weighted study

AB Ingason, JP Hreinsson, AS Ágústsson… - Annals of Internal …, 2021 - acpjournals.org
Background: Gastrointestinal bleeding (GIB) rates for direct oral anticoagulants (DOACs)
and warfarin have been extensively compared. However, population-based studies …

Effectiveness and safety of four direct oral anticoagulants in Asian patients with nonvalvular atrial fibrillation

YH Chan, HF Lee, LC See, HT Tu, TF Chao, YH Yeh… - Chest, 2019 - Elsevier
Background Whether four direct oral anticoagulants (DOACs) are superior to warfarin in
Asian patients with nonvalvular atrial fibrillation (NVAF) remains unclear. Methods This …

Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis

A Plessier, O Goria, JP Cervoni, I Ollivier… - NEJM …, 2022 - evidence.nejm.org
Background In patients with noncirrhotic chronic portal vein thrombosis (PVT), the benefit of
long-term anticoagulation is unknown. We assessed the effects of rivaroxaban on the risk of …

Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian …

MG Abrignani, L Gatta, D Gabrielli, G Milazzo… - European Journal of …, 2021 - Elsevier
Aspirin and P2Y 12 receptor antagonists are widely used across the spectrum of
cardiovascular and cerebrovascular diseases. Gastrointestinal complications, including …